Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
3.620
-0.180 (-4.74%)
At close: Apr 28, 2026, 4:00 PM EDT
3.600
-0.020 (-0.55%)
After-hours: Apr 28, 2026, 6:38 PM EDT
LIXT Market Cap
LIXT has a market cap or net worth of $42.06 million as of April 28, 2026. Its market cap has increased by 1,301.90% in one year.
Market Cap
42.06M
Enterprise Value
37.75M
1-Year Change
1,301.90%
Ranking
Category
Stock Price
$3.62
Market Cap Chart
Since November 25, 2020, LIXT's market cap has decreased from $47.40M to $42.06M, a decrease of -11.27%. That is a compound annual growth rate of -2.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 44.10M | 96.88% |
| Dec 31, 2025 | 22.40M | 386.96% |
| Dec 31, 2024 | 4.60M | -13.21% |
| Dec 29, 2023 | 5.30M | -37.65% |
| Dec 30, 2022 | 8.50M | -48.17% |
| Dec 31, 2021 | 16.40M | -59.20% |
| Dec 31, 2020 | 40.20M | -15.19% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nutriband | 47.29M |
| Atossa Therapeutics | 46.93M |
| Rallybio | 46.44M |
| Dogwood Therapeutics | 44.76M |
| Mereo BioPharma Group | 44.72M |
| Lite Strategy | 42.54M |
| Sensei Biotherapeutics | 42.27M |
| Rein Therapeutics | 41.78M |